The largest database of trusted experimental protocols

Inveon preclinical small animal pet computerized tomography system

Manufactured by Siemens

The Siemens Inveon preclinical small-animal PET/computerized tomography (CT) system is a laboratory equipment designed for the acquisition of high-resolution, three-dimensional images of small animals. The system combines positron emission tomography (PET) and computed tomography (CT) technologies to provide comprehensive data on the anatomical and functional characteristics of the subject under investigation.

Automatically generated - may contain errors

2 protocols using inveon preclinical small animal pet computerized tomography system

1

Evaluating Ceritinib Efficacy in H3122 Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old female NOD/SCID mice (Jackson Labs, Bar Harbor, ME) were implanted subcutaneously at the right flank with 5 × 106 H3122 cells. Tumor volumes were determined using a caliper and calculated with the formula: 0.5 × width2 × length. Once the tumor volume reached 100-150 mm3, mice were divided randomly to be treated with ceritinib at 25 mg/kg or vehicle by oral gavage (8 mice/group). Before drug treatment, mice with H3122 xenografts were scanned with the Inveon preclinical small-animal PET/computerized tomography (CT) system (Siemens Healthcare, Malvern, PA) one hour after intravenous injection of 300 μCi of 18F-FDG (IBA Molecular Inc., Sterling, VA). The mice underwent repeat PET/CT imaging after 2.5 and 5 days of daily treatment with ceritinib or vehicle. The 18F-FDG uptake was expressed as the percentage injected dose per gram tissue (%ID/g). All animal experiments were conducted in compliance with the policies and regulations of VCU IACUC.
+ Open protocol
+ Expand
2

Evaluating Ceritinib Efficacy in H3122 Xenografts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old female NOD/SCID mice (Jackson Labs, Bar Harbor, ME) were implanted subcutaneously at the right flank with 5 × 106 H3122 cells. Tumor volumes were determined using a caliper and calculated with the formula: 0.5 × width2 × length. Once the tumor volume reached 100-150 mm3, mice were divided randomly to be treated with ceritinib at 25 mg/kg or vehicle by oral gavage (8 mice/group). Before drug treatment, mice with H3122 xenografts were scanned with the Inveon preclinical small-animal PET/computerized tomography (CT) system (Siemens Healthcare, Malvern, PA) one hour after intravenous injection of 300 μCi of 18F-FDG (IBA Molecular Inc., Sterling, VA). The mice underwent repeat PET/CT imaging after 2.5 and 5 days of daily treatment with ceritinib or vehicle. The 18F-FDG uptake was expressed as the percentage injected dose per gram tissue (%ID/g). All animal experiments were conducted in compliance with the policies and regulations of VCU IACUC.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!